1-7 of 7
Sujata P. Sarda, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Burden of Paroxysmal Nocturnal Hemoglobinuria Among Patients Receiving C5 Inhibitors in the United States

David Dingli, MD PhD, Joana E. Matos, PhD, Kerri Lehrhaupt, BSc, Sangeeta Krishnan, PharmD, MS, Sujata P. Sarda, PhD, Scott B. Baver, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2.
https://doi.org/10.1182/blood-2020-141844
Published: 2020
Journal Articles

Work Productivity Loss and Quality of Life in Paroxysmal Nocturnal Hemoglobinuria Among Patients Receiving C5 Inhibitors in the United States

David Dingli, MD PhD, Joana E. Matos, PhD, Kerri Lehrhaupt, BSc, Sangeeta Krishnan, PharmD, MS, Scott B. Baver, PhD, Sujata P. Sarda, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3.
https://doi.org/10.1182/blood-2020-142327
Published: 2020
Journal Articles

Improvements in Fatigue Correlate with Changes in Clinical and Hematological Outcomes: Post Hoc Analyses from the Pegasus Study

David Cella, PhD, William R. Lenderking, PhD, Sujata P. Sarda, PhD, Scott B. Baver, PhD, Mohamed Hamdani, MS, Ray Hsieh, MS, Shannon Shaffer, MS, Alexander Röth, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-142354
Published: 2020
Journal Articles

Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population

Wendy Y Cheng, PhD MPH, Sujata P. Sarda, PhD, Nikita Mody-Patel, PharmD, MBA, Sangeeta Krishnan, PharmD, MS, Mihran Yenikomshian, MBA, Patrick J. Scoble, PharmD, Colin Kunzweiler, PhD MS, Jensen Duy Vu, BA, Hoi Ching Cheung, BA, Mei Sheng Duh, ScD, MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 13.
https://doi.org/10.1182/blood-2020-141636
Published: 2020
Journal Articles

Real-World Treatment Patterns and Healthcare Resource Utilization (HRU) of Patients (Pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population

Wendy Y Cheng, PhD MPH, Sujata P. Sarda, PhD, Nikita Mody-Patel, PharmD, MBA, Sangeeta Krishnan, PharmD, MS, Mihran Yenikomshian, MBA, Patrick J. Scoble, PharmD, Malena Mahendran, MSc, Dominique Lejeune, MSc, Louise Yu, MSc, Mei Sheng Duh, ScD, MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-141648
Published: 2020
Journal Articles

Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab

Alexander Röth, MD, Britta Hoechsmann, Morag Griffin, MBChB, FRCPath, Carlos M. de Castro, MD, Jeffrey Szer, MBBS, Kensuke Usuki, MD PhD, Juliette Soret, MD, Mohamed Hamdani, MS, Temitayo Ajayi, Sujata P. Sarda, PhD, Jens Panse, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–12.
https://doi.org/10.1182/blood-2020-134581
Published: 2020
Journal Articles

Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Previously Treated with Eculizumab: A Matching-Adjusted Indirect Comparison

Rachel Y Bhak, MS, Nikita Mody-Patel, PharmD, MBA, Scott B. Baver, PhD, Colin Kunzweiler, PhD MS, Christopher Yee, ScM, Sanjana Sundaresan, ScM, Natalia Swartz, MPH, Mei Sheng Duh, ScD, MPH, Sangeeta Krishnan, PharmD, MS, Sujata P. Sarda, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-141667
Published: 2020